These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7973902)

  • 1. Dapsone therapy causing sulfone syndrome and lethal hepatic failure in an HIV-infected patient.
    Chalasani P; Baffoe-Bonnie H; Jurado RL
    South Med J; 1994 Nov; 87(11):1145-6. PubMed ID: 7973902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse reactions associated with dapsone therapy in HIV-positive patients: a case presentation and review.
    Stroup JS; Stephens JR; Reust R; Miller JA
    AIDS Read; 2006 Jan; 16(1):47-8, 53-5; discussion 54-5. PubMed ID: 16433472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfone syndrome in a patient receiving steroids for pemphigus.
    Barnard GF; Scharf MJ; Dagher RK
    Am J Gastroenterol; 1994 Nov; 89(11):2057-9. PubMed ID: 7942736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sulfone syndrome secondary to dapsone prophylaxis in a patient undergoing unrelated hematopoietic stem cell transplantation.
    Abidi MH; Kozlowski JR; Ibrahim RB; Peres E
    Hematol Oncol; 2006 Sep; 24(3):164-5. PubMed ID: 16639690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sulfone syndrome in a patient receiving dapsone prophylaxis for Pneumocystis carinii pneumonia.
    Mohle-Boetani J; Akula SK; Holodniy M; Katzenstein D; Garcia G
    West J Med; 1992 Mar; 156(3):303-6. PubMed ID: 1595261
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute generalised exanthematous pustulosis induced by Pneumocystis jirovecii pneumonia prophylaxis with dapsone.
    Vas A; Laws P; Marsland A; McQuillan O
    Int J STD AIDS; 2013 Sep; 24(9):745-7. PubMed ID: 24026795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A lethal case of the dapsone hypersensitivity syndrome involving the myocardium.
    Hoogeveen RM; van der Bom T; de Boer HH; Thurlings RM; Wind BS; de Vries HJ; van Lent AU; Beuers U; van der Wal AC; Nellen FJ
    Neth J Med; 2016 Feb; 74(2):89-92. PubMed ID: 26951355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dapsone-induced sulfone syndrome.
    Lee KB; Nashed TB
    Ann Pharmacother; 2003; 37(7-8):1044-6. PubMed ID: 12841817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful desensitization to dapsone for Pneumocystis carinii prophylaxis in an HIV-positive patient.
    Cook DE; Kossey JL
    Ann Pharmacother; 1998 Dec; 32(12):1302-5. PubMed ID: 9876811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver involvement in the sulfone syndrome.
    Johnson DA; Cattau EL; Kuritsky JN; Zimmerman HJ
    Arch Intern Med; 1986 May; 146(5):875-7. PubMed ID: 3963977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dapsone hypersensitivity. The sulfone syndrome revisited.
    Tomecki KJ; Catalano CJ
    Arch Dermatol; 1981 Jan; 117(1):38-9. PubMed ID: 6450569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron overload as a mechanism for the lowered survival in AIDS patients receiving dapsone-iron protoxalate for secondary prophylaxis of Pneumocystis carinii pneumonia.
    Weinberg GA
    J Infect Dis; 1996 Jul; 174(1):241-2. PubMed ID: 8656006
    [No Abstract]   [Full Text] [Related]  

  • 13. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.
    Podzamczer D; Salazar A; Jiménez J; Consiglio E; Santín M; Casanova A; Rufí G; Gudiol F
    Ann Intern Med; 1995 May; 122(10):755-61. PubMed ID: 7717598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.
    Warnock AC; Rimland D
    Pharmacotherapy; 1996; 16(6):1030-8. PubMed ID: 8947975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
    Torres RA; Barr M; Thorn M; Gregory G; Kiely S; Chanin E; Carlo C; Martin M; Thornton J
    Am J Med; 1993 Dec; 95(6):573-83. PubMed ID: 8018144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does dapsone increase mortality when given for prophylaxis of Pneumocystis carinii pneumonia?
    Opravil M; Hirschel B; Lüthy R
    AIDS; 1996 Aug; 10(9):1045-6. PubMed ID: 8853742
    [No Abstract]   [Full Text] [Related]  

  • 17. [Disulone hypersensitivity syndrome].
    Risse L; Bernard P; Brosset A; Enginger V; Bedane C; Bonnetblanc JM
    Ann Dermatol Venereol; 1994; 121(3):242-4. PubMed ID: 7832554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dapsone induced cholangitis as a part of dapsone syndrome: a case report.
    Itha S; Kumar A; Dhingra S; Choudhuri G
    BMC Gastroenterol; 2003 Aug; 3():21. PubMed ID: 12911838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic and pulmonary pneumocystosis during primary prophylaxis for Pneumocystis carinii pneumonia with dapsone/pyrimethamine.
    Podzamczer D; Martos A; Ferrer I; Santin M; Gudiol F
    Clin Infect Dis; 1993 Jan; 16(1):171. PubMed ID: 8448298
    [No Abstract]   [Full Text] [Related]  

  • 20. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.
    Bozzette SA; Finkelstein DM; Spector SA; Frame P; Powderly WG; He W; Phillips L; Craven D; van der Horst C; Feinberg J
    N Engl J Med; 1995 Mar; 332(11):693-9. PubMed ID: 7854375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.